BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Praveen P, Kocan M, Valkovic A, Bathgate R, Hossain MA. Single chain peptide agonists of relaxin receptors. Molecular and Cellular Endocrinology 2019;487:34-9. [DOI: 10.1016/j.mce.2019.01.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 D'ercole A, Nistri S, Pacini L, Carotenuto A, Santoro F, Papini AM, Bathgate RAD, Bani D, Rovero P. Synthetic short-chain peptide analogues of H1 relaxin lack affinity for the RXFP1 receptor and relaxin-like bioactivity. Clues to a better understanding of relaxin agonist design. Front Pharmacol 2022;13:942178. [DOI: 10.3389/fphar.2022.942178] [Reference Citation Analysis]
2 Gay EA, Guan D, Van Voorhies K, Vasukuttan V, Mathews KM, Besheer J, Jin C. Discovery and Characterization of the First Nonpeptide Antagonists for the Relaxin-3/RXFP3 System. J Med Chem 2022. [PMID: 35594150 DOI: 10.1021/acs.jmedchem.2c00508] [Reference Citation Analysis]
3 Abboud C, Brochoire L, Drouet A, Hossain MA, Hleihel W, Gundlach AL, Landry M. Analgesic effect of central relaxin receptor activation on persistent inflammatory pain in mice: behavioral and neurochemical data. Pain Rep 2021;6:e937. [PMID: 34159282 DOI: 10.1097/PR9.0000000000000937] [Reference Citation Analysis]
4 Ezhilarasan D. Relaxin in hepatic fibrosis: What is known and where to head? Biochimie 2021;187:144-51. [PMID: 34102254 DOI: 10.1016/j.biochi.2021.06.001] [Reference Citation Analysis]
5 Karas JA, Wade JD, Hossain MA. The Chemical Synthesis of Insulin: An Enduring Challenge. Chem Rev 2021;121:4531-60. [PMID: 33689304 DOI: 10.1021/acs.chemrev.0c01251] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Deadder NP, Gillam HJ, Wilson BC, Hogan MJ. Relaxin peptides reduce cellular damage in cultured brain slices exposed to transient oxygen–glucose deprivation: an effect mediated by nitric oxide. FACETS 2021;6:118-30. [DOI: 10.1139/facets-2020-0029] [Reference Citation Analysis]
7 Praveen P, Tailhades J, Rosengren KJ, Liu M, Wade JD, Bathgate RAD, Hossain MA. Effects of C-Terminal B-Chain Modifications in a Relaxin 3 Agonist Analogue. ACS Med Chem Lett 2020;11:2336-40. [PMID: 33214850 DOI: 10.1021/acsmedchemlett.0c00456] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Eiden LE, Gundlach AL, Grinevich V, Lee MR, Mecawi AS, Chen D, Buijs RM, Hernandez VS, Fajardo-Dolci G, Zhang L. Regulatory peptides and systems biology: A new era of translational and reverse-translational neuroendocrinology. J Neuroendocrinol 2020;32:e12844. [PMID: 32307768 DOI: 10.1111/jne.12844] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Cazzola M, Rogliani P, Matera MG. The future of bronchodilation: looking for new classes of bronchodilators. Eur Respir Rev 2019;28:190095. [PMID: 31871127 DOI: 10.1183/16000617.0095-2019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]